Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 44, 2010 - Issue 6
Submit an article Journal homepage
316
Views
8
CrossRef citations to date
0
Altmetric
Urology

Impacts of leuprolide acetate on quality of life in patients with prostate cancer: A prospective multicenter study

Dalsan You Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
,
In Gab Jeong Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
,
Sae Woong Kim Department of Urology, The Catholic University of Korea College of Medicine, Seoul, South Korea
,
Byung Ha Chung Department of Urology, Yonsei University College of Medicine, Seoul, South Korea
,
Jin Seon Cho Department of Urology, Hallym University College of Medicine, Chuncheon, South Korea
,
Hyun Moo Lee Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
,
Sung-Cheol Yun Clinical Research Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
&
Choung-Soo Kim Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South KoreaCorrespondence[email protected]
 show all
Pages 399-405 | Received 24 Oct 2009, Accepted 07 Jul 2010, Published online: 13 Aug 2010

References

  • Park SK, Sakoda LC, Kang D, Chokkalingam AP, Lee E, Shin HR, Rising prostate cancer rates in South Korea. Prostate 2006;66:1285–91.
  • Cookson MM. Prostate cancer: screening and early detection. Cancer Control 2001;8:133–40.
  • Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR, Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE). Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer 2008;112:307–14.
  • Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid HP, EAU guidelines on prostate cancer. Eur Urol 2008;53:68–80.
  • Wu AH, Whittemore AS, Kolonel LN, John EM, Gallagher RP, West DW, Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African–American, white, and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev 1995;4:735–41.
  • Pettaway CA. Racial differences in the androgen/androgen receptor pathway in prostate cancer. J Natl Med Assoc 1999;91:653–60.
  • Hong SK, Han BK, Jeong JS, Jeong SJ, Moon KH, Byun SS, Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men. Asian J Androl 2008;10:207–13.
  • Iversen P, Rasmussen F, Christensen IJ. Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma. Scand J Urol Nephrol Suppl 1994;157:41–7.
  • Schatzl G, Madersbacher S, Thurridl T, Waldmuller J, Kramer G, Haitel A, High-grade prostate cancer is associated with low serum testosterone levels. Prostate 2001;47:52–8.
  • Song C, Ro JY, Lee MS, Hong SJ, Chung BH, Choi HY, Prostate cancer in Korean men exhibits poor differentiation and is adversely related to prognosis after radical prostatectomy. Urology 2006;68:820–4.
  • Salonen AJ, Viitanen J, Lundstedt S, Ala-Opas M, Taari K, Tammela TL, FinnProstate Group. Finnish multicenter study comparing intermittent to continuous androgen deprivation for advanced prostate cancer: interim analysis of prognostic markers affecting initial response to androgen deprivation. J Urol 2008;180:915–20.
  • Potosky AL, Knopf K, Clegg LX, Albertsen PC, Stanford JL, Hamilton AS, Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study. J Clin Oncol 2001;19:3750–7.
  • Green HJ, Pakenham KI, Headley BC, Yaxley J, Nicol DL, Mactaggart PN, Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial. BJU Int 2004;93:975–9.
  • da Silva FC, Fossa SD, Aaronson NK, Serbouti S, Denis L, Casselman J, The quality of life of patients with newly diagnosed M1 prostate cancer: experience with EORTC clinical trial 30853. Eur J Cancer 1996;32:72–7.
  • Eton DT, Lepore SJ. Prostate cancer and health-related quality of life: a review of the literature. Psychooncology 2002;11:307–26.
  • Litwin MS, Shpall AI, Dorey F, Nguyen TH. Quality-of-life outcomes in long-term survivors of advanced prostate cancer. Am J Clin Oncol 1998;21:327–32.
  • Cassileth BR, Soloway MS, Vogelzang NJ, Chou JM, Schellhammer PD, Seidmon EJ, Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group. Qual Life Res 1992;1:323–9.
  • Albertsen PC, Aaronson NK, Muller MJ, Keller SD, Ware JE Jr. Health-related quality of life among patients with metastatic prostate cancer. Urology 1997;49:207–17.
  • Spry NA, Kristjanson L, Hooton B, Hayden L, Neerhut G, Gurney H, Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer. Eur J Cancer 2006;42:1083–92.
  • Ramsey SD, Zeliadt SB, Hall IJ, Ekwueme DU, Penson DF. On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer. J Urol 2007;177:1992–9.
  • Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 2002;94:334–57.
  • Rose A, Peters N, Shea JA, Armstrong K. Development and testing of the health care system distrust scale. J Gen Intern Med 2004;19:57–63.
  • Lubeck DP, Kim H, Grossfeld G, Ray P, Penson DF, Flanders SC, Health related quality of life differences between black and white men with prostate cancer: data from the cancer of the prostate strategic urologic research endeavor. J Urol 2001;166:2281–5.
  • Penson DF, Stoddard ML, Pasta DJ, Lubeck DP, Flanders SC, Litwin MS. The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer. J Clin Epidemiol 2001;54:350–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.